Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Esophageal Squamous Cell Carcinoma 7 Rectal Neoplasms 4 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 HER2-positive Breast Cancer 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of External Auditory Canal 1 Seminoma 1 Recurrence 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1

Interventions

pembrolizumab 25 Paclitaxel 20 Carboplatin 17 Bevacizumab 12 Specimen Handling 10 Letrozole 10 abemaciclib 7 dostarlimab 6 Taxes 6 Blood Specimen Collection 6 Medroxyprogesterone Acetate 5 Magnetic Resonance Spectroscopy 5 Fulvestrant 5 Drug Therapy 5 Doxorubicin 5 Cisplatin 5 Biopsy 5 olaparib 4 lenvatinib 4 atezolizumab 4 Radiotherapy 4 Progestins 4 Observation 4 Nivolumab 4 Megestrol Acetate 4 Immunoglobulin G 4 Gemcitabine 4 trastuzumab deruxtecan 3 palbociclib 3 X-Rays 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Endometrial Neoplasms × Neoadjuvant Therapy × Clear all

NCT05179447 2025-04-01

PROBEAT

Women's Hospital School Of Medicine Zhejiang University

Phase NA Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡